Instructor: Dr. Debmalya Sengupta
Validity Period: Lifetime
What is the Stem cell:
Viral-mediated gene augmentation therapy has recently shown success in restoring vision to patients with retinal degenerative disorders. Key to this success was the availability of animal models that accurately presented the human phenotype to test preclinical efficacy and safety. These exciting studies support the use of gene therapy in the treatment of devastating retinal degenerative diseases. In some cases, however, in vivo gene therapy for retinal degeneration would not be effective because the cell types targeted are no longer present. The development of somatic cell reprogramming methods provides an attractive source of autologous cells for transplantation and treatment of retinal degenerative disease. This article explores the development of gene therapy and patient-derived stem cells for the purpose of restoring vision to individuals suffering from inherited retinal degenerations.
Duration- 3 Days (6 Hours)
Dates: 12th July 2021
Certificate: All learners will get the course completion certificate.
What Benefits are you going to get from this course?
For more information whastapp us: +1 407 635 1011, email@example.com
|Introduction to Stem Cells|
|Stem Dell Division and Differentiation|
|Recording - Class 1: Stem cell & Gene Therapy-Rec|
|Stem Cell Differentiation factors and integration|
|Recording - C2: Stem Cell|
|Stem Cell therapy|
|Stem Cell & Gene Therapy: Application & Bioethics|
|Application and Bioethics|
|Guidelines, Ethics and Future|
|Guidelines, Ethics in India and Future|
After successful purchase, this item would be added to your courses.
You can access your courses in the following ways :